|
|
Article: Allergan Files Federal Lawsuit to Allow It to Share Relevant Information with the Medical Community on the Safe Use of BOTOX[R] for Common Therapeutic Off-Label Treatments.
- Article from:
- Business Wire
- Article date:
- October 2, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
IRVINE, Calif. -- Allergan, Inc. (NYSE: AGN) today filed a declaratory relief action in the United States District Court for the District of Columbia seeking a ruling that would allow Allergan to proactively share truthful and relevant information with the medical community to assist physicians in evaluating the risks and benefits of BOTOX([R]) (onabotulinumtoxinA) for certain "off-label" therapeutic uses. Some of these off-label uses are medically accepted and commonly prescribed but currently unapproved by the United States Food and Drug Administration (FDA). In the lawsuit, Allergan contends that the Government's legal position that it is a crime for a pharmaceutical ...
Related newspaper, magazine, and journal articles:
|
|
Transcript: SECRETARY THOMPSON URGES MEDICAL COMMUNITY TO ...
Regulatory Intelligence Data;
January 7, 2005 ;
700+ words
... ... Thompson today urged the medical community to do all it can ... of the continued United States response to the tsunami ... meeting to update the medical community -- including health ... companies -- on the United States' response to the ...
|
|